Tim Kutzkey, Ph.D., is a Managing Partner of both The Column Group and TCG Labs-Soleil. Since joining the firm in 2007 he has contributed to the conception, formation, and management of nearly two dozen portfolio companies. Formerly, he was the founding CEO of Peloton Therapeutics, Neurona, and Surrozen. He was also Chairman of the Board of Directors of Carmot and Nurix Therapeutics. Prior to joining The Column Group, Dr. Kutzkey was a scientist at KAI Pharmaceuticals where he focused on the discovery and development of selective protein kinase C inhibitors. Before KAI, he worked at UC Berkeley as a graduate student and postdoc in the lab of Dr. Robert Tjian, completing his Ph.D. in 2005. Dr. Kutzkey was previously educated at Stanford University.